132 related articles for article (PubMed ID: 26883958)
1. Disruption of brain zinc homeostasis promotes the pathophysiological progress of Alzheimer's disease.
Li LB; Wang ZY
Histol Histopathol; 2016 Jun; 31(6):623-7. PubMed ID: 26883958
[TBL] [Abstract][Full Text] [Related]
2. Zinc overload enhances APP cleavage and Aβ deposition in the Alzheimer mouse brain.
Wang CY; Wang T; Zheng W; Zhao BL; Danscher G; Chen YH; Wang ZY
PLoS One; 2010 Dec; 5(12):e15349. PubMed ID: 21179415
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
4. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
5. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
6. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G
Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional roles of zinc in Alzheimer's disease.
Xie Z; Wu H; Zhao J
Neurotoxicology; 2020 Sep; 80():112-123. PubMed ID: 32717200
[TBL] [Abstract][Full Text] [Related]
8. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
9. Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain.
Zhang LH; Wang X; Zheng ZH; Ren H; Stoltenberg M; Danscher G; Huang L; Rong M; Wang ZY
Neurobiol Aging; 2010 Jan; 31(1):74-87. PubMed ID: 18378045
[TBL] [Abstract][Full Text] [Related]
10. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.
Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY
Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746
[TBL] [Abstract][Full Text] [Related]
11. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.
Sensi SL; Rapposelli IG; Frazzini V; Mascetra N
Exp Gerontol; 2008 May; 43(5):488-92. PubMed ID: 18068923
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease, beta-amyloid protein and zinc.
Huang X; Cuajungco MP; Atwood CS; Moir RD; Tanzi RE; Bush AI
J Nutr; 2000 May; 130(5S Suppl):1488S-92S. PubMed ID: 10801964
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.
Tan J; Town T; Crawford F; Mori T; DelleDonne A; Crescentini R; Obregon D; Flavell RA; Mullan MJ
Nat Neurosci; 2002 Dec; 5(12):1288-93. PubMed ID: 12402041
[TBL] [Abstract][Full Text] [Related]
16. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
17. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
19. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
20. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
